PARA rod stock from Drake Medical Plastics / Alternative to prototype tooling for single-use medical devices
Solvay’s (Brussels / Belgium; “Ixef” polyarylamide (PARA) is now available in rod stock from its distribution partner Drake Medical Plastics (Cypress, Texas / USA; The materials have been evaluated for ISO 10993 limited-duration biocompatibility and are supported by a US Food and Drug Administration (FDA) master access file (MAF).

The medical-grade and 50% glass fibre-reinforced Ixef stock shapes feature good rigidity, creep resistance, strength, biocompatibility and light weight. They can be precisely machined to create appearance prototypes of single-use orthopedic surgical instruments, an approach that avoids the considerable time and expense of producing soft tooling. Once the part design is finalised, device manufacturers can fully leverage the performance properties of Ixef PARA resin using injection moulding.
26.06.2019 [242760-0]
Published on 26.06.2019
Drake Medical Plastics: Distribution von Polyarylamid-RundstäbenGerman version of this article...

© 2001-2019  |  Imprint  |  Privacy is a business information platform for the European plastics industry. It is part of KI Kunststoff Information and PIE Plastics Information Europe, one of the leading content providers for the European plastics industry. We offer daily updated business news and reports, in-depth market analysis, polymer prices and other services for the international plastics industry, including a suppliers guide, career opportunities, a trade name directory and videos.

News | Polymer Prices | Material Databases | Plastics Exchange | Suppliers Guide | Jobs | Trade Names | Videos | Associations & Institutions | Register | Advertising

PIE – Plastics Information Europe | KI – Kunststoff Information | KunststoffWeb | Plastics Material Exchange | Polyglobe | K-Profi
© 2001-2019 by, Bad Homburg
Date of print: 23.08.2019 20:01:19   (Ref: 1043371114)
Text and images are subject to copyright and other laws for protection of intellectual property.
Any duplication or distribution in any media as a whole or in parts requires prior written approval by Plasteurope. URL: